Lincoln Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE405C01035
  • NSEID: LINCOLN
  • BSEID: 531633
INR
483.60
7.85 (1.65%)
BSENSE

Dec 19

BSE+NSE Vol: 13.29 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryLincoln Pharma. VS Pharmaceuticals & Biotechnology
 
1D
1.65%
0.58%
1W
2.27%
-0.31%
1M
-10.09%
-0.33%
YTD
-38.61%
9.82%
1Y
-40.56%
8.41%
3Y
31.15%
40.97%
5Y
108.99%
88.7%
10Y
124.72%
234.53%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.37%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.86%
0%
-12.86%
6 Months
-14.32%
0.32%
-14.0%
1 Year
-40.56%
0.23%
-40.33%
2 Years
-23.72%
0.28%
-23.44%
3 Years
31.15%
0.94%
32.09%
4 Years
39.71%
1.32%
41.03%
5 Years
108.99%
2.67%
111.66%

Latest dividend: 1.8 per share ex-dividend date: Sep-12-2025

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Lincoln Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-9.13%
3
Quartile
quartile-3
Jun-Sep
-5.93%
3
Quartile
quartile-3
Mar-Jun
2.58%
4
Quartile
quartile-4
YTD
-40.45%
2
Quartile
quartile-2
2024
29.25%
3
Quartile
quartile-3
2023
71.42%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Lincoln Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-9.13%
2
Quartile
quartile-2
Jun-Sep
-5.93%
3
Quartile
quartile-3
Mar-Jun
2.58%
4
Quartile
quartile-4
YTD
-40.45%
2
Quartile
quartile-2
2024
29.25%
1
Quartile
quartile-1
2023
71.42%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Lincoln Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-9.13%
2
Quartile
quartile-2
Jun-Sep
-5.93%
4
Quartile
quartile-4
Mar-Jun
2.58%
3
Quartile
quartile-3
YTD
-40.45%
2
Quartile
quartile-2
2024
29.25%
1
Quartile
quartile-1
2023
71.42%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available